Statistical analyses based on categorized data (i.e., increased, unaltered, decreased proliferation) showed associations between the CXCR4 mediated antiproliferative effect and monocytic AML cell differentiation (p = 0.009) and favorable karyotype (p = 0.025). This evidence concerns the gene CXCR4 and acute myeloid leukemia.